APMD (Apnimed) Net Interest Income: $1.41 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APMD Apnimed Inc APMD
8 GF Score
Price $27.12
View Full Analysis

What is Apnimed Net Interest Income?

Apnimed APMD +5.99% 8 Net Interest Income is $1.41 Mil as of Jun. 2026. GuruFocus rates APMD with a GF Score™ of 8/100.

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Apnimed's net interest income for the three months ended in Jun. 2026 was $0.97 Mil. Its net interest income for the trailing twelve months (TTM) ended in Jun. 2026 was $1.41 Mil.

Apnimed Net Interest Income Related Terms

Apnimed Net Interest Income Historical Data

* Premium members only.

The historical data trend for Apnimed's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apnimed Net Interest Income Chart

Apnimed Annual Data
Trend Dec24 Dec25
Net Interest Income
5.68 1.41

Apnimed Quarterly Data
Mar25 Jun25 Mar26 Jun26
Net Interest Income 0.43 0.31 0.22 0.97
APMD
8GF Score
Apnimed Inc APMD
Net Interest Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apnimed Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Interest Income →
What does a Net Interest Income of $1.41 Mil mean?
Apnimed (APMD) has a Net Interest Income of $1.41 Mil as of Jun. 2026.
Is Apnimed's Net Interest Income too high?
Apnimed's current Net Interest Income is $1.41 Mil. Overall, Apnimed has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Apnimed's Net Interest Income compare to SANA and CRVS?
Apnimed's Net Interest Income of $1.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Interest Income for a Biotechnology company?
A good Net Interest Income depends on the Biotechnology industry context. However, Net Interest Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Interest Income mean?
A high Net Interest Income can signal that a stock is expensive relative to its fundamentals. Apnimed's current Net Interest Income is $1.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apnimed stock overvalued right now?
Apnimed (APMD) has a current Net Interest Income of $1.41 Mil. The current Net Interest Income is $1.41 Mil. Apnimed's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Interest Income calculated?
Net Interest Income is calculated from a company's financial statements. For Apnimed (APMD), the current Net Interest Income is $1.41 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apnimed Business Description

Address 39 John F. Kennedy Street, 4th Floor, Cambridge, MA, USA, 02138
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
8GF Score

Get the complete analysis for APMD

Net Interest Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$27.12
Price